Strata Critical Medical, Inc. (SRTA)
4.68
+0.34
(+7.83%)
USD |
NASDAQ |
Oct 16, 10:40
Strata Critical Medical Research and Development Expense (Quarterly) : 1.006M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.006M |
| March 31, 2026 | 1.118M |
| December 31, 2025 | 1.698M |
| September 30, 2025 | 0.453M |
| June 30, 2025 | 0.696M |
| March 31, 2025 | 0.719M |
| December 31, 2024 | 1.759M |
| September 30, 2024 | 0.417M |
| June 30, 2024 | 0.971M |
| March 31, 2024 | 0.67M |
| December 31, 2023 | 0.988M |
| Date | Value |
|---|---|
| September 30, 2023 | 1.076M |
| June 30, 2023 | 1.44M |
| March 31, 2023 | 1.123M |
| December 31, 2022 | 1.622M |
| September 30, 2022 | 2.026M |
| June 30, 2022 | 1.062M |
| December 31, 2021 | 0.649M |
| September 30, 2021 | 0.959M |
| June 30, 2021 | 0.213M |
| March 31, 2021 | |
| December 31, 2020 | 0.342M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median